These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. Desikan RS; McEvoy LK; Holland D; Thompson WK; Brewer JB; Aisen PS; Andreassen OA; Hyman BT; Sperling RA; Dale AM; AJNR Am J Neuroradiol; 2013 Mar; 34(3):505-10. PubMed ID: 22976236 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
6. Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS). Saunders TS; Jenkins N; Blennow K; Ritchie C; Muniz-Terrera G EBioMedicine; 2022 Sep; 83():104241. PubMed ID: 36041266 [TBL] [Abstract][Full Text] [Related]
7. Sex differences in CSF biomarkers vary by Alzheimer disease stage and Babapour Mofrad R; Tijms BM; Scheltens P; Barkhof F; van der Flier WM; Sikkes SAM; Teunissen CE Neurology; 2020 Oct; 95(17):e2378-e2388. PubMed ID: 32788242 [TBL] [Abstract][Full Text] [Related]
8. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT; Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664 [TBL] [Abstract][Full Text] [Related]
9. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study. Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550 [TBL] [Abstract][Full Text] [Related]
10. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Vemuri P; Wiste HJ; Weigand SD; Knopman DS; Shaw LM; Trojanowski JQ; Aisen PS; Weiner M; Petersen RC; Jack CR; Ann Neurol; 2010 Mar; 67(3):308-16. PubMed ID: 20373342 [TBL] [Abstract][Full Text] [Related]
11. Association of APOE gene with longitudinal changes of CSF amyloid beta and tau levels in Alzheimer's disease: racial differences. Xu C; Xiao D; Su BB; Saveron JM; Gamez D; Navia RO; Wang N; Roy U; Adjeroh DA; Wang K; Neurol Sci; 2024 Mar; 45(3):1041-1050. PubMed ID: 37759100 [TBL] [Abstract][Full Text] [Related]
12. The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment. Luo Y; Tan L; Therriault J; Zhang H; Gao Y; Eur Neurol; 2021; 84(6):472-480. PubMed ID: 34340229 [TBL] [Abstract][Full Text] [Related]
17. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds. Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503 [TBL] [Abstract][Full Text] [Related]
18. Associations between cardiometabolic multimorbidity and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: the CABLE study. Li QY; Hu HY; Zhang GW; Hu H; Ou YN; Huang LY; Wang AY; Gao PY; Ma LY; Tan L; Yu JT Alzheimers Res Ther; 2024 Feb; 16(1):28. PubMed ID: 38321520 [TBL] [Abstract][Full Text] [Related]
19. Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype. Blom ES; Giedraitis V; Zetterberg H; Fukumoto H; Blennow K; Hyman BT; Irizarry MC; Wahlund LO; Lannfelt L; Ingelsson M Dement Geriatr Cogn Disord; 2009; 27(5):458-64. PubMed ID: 19420940 [TBL] [Abstract][Full Text] [Related]